Retinal degeneration

Retinal degeneration refers to the progressive loss of photoreceptor cells, such as rods and cones, which leads to severe visual impairment in conditions like retinitis pigmentosa and age-related macular degeneration (NIH, 2023). The transplantation of human rod precursor cells is a regenerative medicine approach designed to replace these lost cells and restore the retina's light-sensing capabilities (Pearson et al., 2012). These precursor cells are typically derived from pluripotent stem cells and are characterized by the expression of transcription factors like CRX and NRL, which are essential for rod photoreceptor development (Lamba et al., 2009). Once transplanted, these cells aim to integrate into the host retinal architecture and form functional synapses with the remaining neural circuitry (Gamm et al., 2015). In addition to direct cell replacement, the transplanted precursors may provide neurotrophic support to surviving host cells, potentially slowing the overall rate of degeneration (Science Translational Medicine, 2015). This therapeutic strategy is not directed at a single molecular target but rather addresses the complex pathological environment of the degenerating retina. Clinical implementation faces challenges such as ensuring long-term graft survival, preventing immune rejection, and avoiding the risk of ectopic tissue formation or tumorigenicity (PubMed: 28537477). Monitoring the success of such interventions involves high-resolution imaging techniques like optical coherence tomography and functional assessments via electroretinography to confirm graft integration.

Other names

Retinal dystrophyPhotoreceptor degenerationRetinal cell lossDegenerating retinal tissue

Cell replacement and neurotrophic support via transplantation of rod precursor cells to restore visual function.